Table 7.
Percentage susceptibilities of the isolates to the first-line drugs tested
| Drug | Isolates tested | |||||
| Staph.spps | Strep.spps | Coliforms | E.coli | Proteus | Kleb.spps | |
| Nitrofurantoin | R (42.1%) | S (54.6%) | S (50%) | S (69.2%) | S (50%) | S (72%) |
| Nalidixic acid | R (23.7%) | R (9.1%) | R (5%) | R (30.8%) | S(66.7%) | R (28%) |
| Erythromycin | S (57.9%) | S (72.7%) | R (15%) | R (23.1%) | R (0%) | R(8%) |
| Cotrimoxazole | R (∼21%) | R(45.4%) | R (5%) | R (7.7%) | R 16.7%) | R (24%) |
| Ciprofloxacin | S (63.2%) | S (72.7%) | S(50%) | S (76.9%) | S(58.3%) | R (24%) |
| Amoxycillin | S (60.5%) | S(72.7%) | R (15%) | R (7.7%) | R(33.3%) | R (4%) |
Key:
S - Susceptible to the drug; R - Resistant to the drug; [xI]- Shows that the numerator in brackets includes ‘xș isolates which showed intermediate susceptibility (I) to the respective drug; X/y - number of isolates that are susceptible to the drug out of the total isolates for that particular organism.